PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory News:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today that its first half 2021 revenue was € 2.2 m at constant exchange rate (cc).
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, declared: “Our excellent sales momentum OUS, especially in Europe, over the last three quarters is ramping-up and we are now back to growth in the United States. This concurrence enables us to deliver a great performance in this second quarter of 2021 with close to 40% global growth at constant exchange rate. This is particularly encouraging considering that our DSG Connect platform is still in pre-launch phase. In addition, we now have the cash runway to fund both our commercial deployment in the United States and our very promising innovation pipeline.”
H1 and Q2 2021 revenues
|
€ thousands – IFRS (Unaudited) |
2021 |
2020 |
Variance |
Var. cc |
|
First Quarter |
1,049 |
1,376 |
-24% |
-19% |
|
Second Quarter |
1,179 |
902 |
+31% |
+39% |
|
Half-Year |
2,228 |
2,278 |
-2% |
+4% |
Outside the USA, the revenue of the second quarter grew by +146% at € 304K. The half-year revenue grew by +59% at € 652K.
In the United States, the revenue of the second quarter 2021 grew by 22% to $ 1,054K from $ 862K (+13% as…
